These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16911392)

  • 1. Unmasking of mixed connective tissue disease by adjuvant IFN alpha therapy for melanoma.
    Trefzer U; Kors C; Voit C; Sterry W
    Int J Dermatol; 2006 Aug; 45(8):984-5. PubMed ID: 16911392
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.
    Bouwhuis MG; Suciu S; Collette S; Aamdal S; Kruit WH; Bastholt L; Stierner U; Salès F; Patel P; Punt CJ; Hernberg M; Spatz A; ten Hagen TL; Hansson J; Eggermont AM;
    J Natl Cancer Inst; 2009 Jun; 101(12):869-77. PubMed ID: 19509353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopathologic study of the skin of patients with mixed connective tissue disease].
    Wang WC
    Zhonghua Yi Xue Za Zhi; 1985 Sep; 65(9):513-6. PubMed ID: 3935284
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mixed connective tissue disease (Sharp syndrome)].
    Lang H; Gläser V; Hourieh M
    Z Gesamte Inn Med; 1980 Nov; 35(22):824-8. PubMed ID: 6970457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mixed connective tissue disease as a neurologic disease picture].
    Hagenah R; Leonhardt KF
    Nervenarzt; 1984 Feb; 55(2):99-102. PubMed ID: 6608059
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mixed connective tissue disease (a review of the literature)].
    Folomeeva OM
    Vopr Revm; 1980; (2):50-3. PubMed ID: 6996325
    [No Abstract]   [Full Text] [Related]  

  • 7. Frontiers in adjuvant therapy in stage II-III melanoma.
    Eggermont AM
    Tumori; 2001; 87(4):S60-3. PubMed ID: 11693827
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmunity and immunotherapy for cancer.
    Koon H; Atkins M
    N Engl J Med; 2006 Feb; 354(7):758-60. PubMed ID: 16481646
    [No Abstract]   [Full Text] [Related]  

  • 9. IFN-α in the treatment of melanoma.
    Tarhini AA; Gogas H; Kirkwood JM
    J Immunol; 2012 Oct; 189(8):3789-93. PubMed ID: 23042723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mixed connective tissue disease].
    Konndo H; Okada J
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Apr; 25(2):215-26. PubMed ID: 12043190
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate].
    Strannegärd O; Thorén FB; Lundgren E
    Lakartidningen; 2008 Feb 6-12; 105(6):358-61. PubMed ID: 18380352
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral blood CD8highCD57+ lymphocyte levels may predict outcome in melanoma patients treated with adjuvant interferon-alpha.
    Characiejus D; Pasukoniene V; Jonusauskaite R; Azlauskaite N; Aleknavicius E; Mauricas M; Otter WD
    Anticancer Res; 2008; 28(2B):1139-42. PubMed ID: 18505049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon for melanoma: another application of immunopharmacology.
    Nauman C
    JAMA; 1998 Apr 22-29; 279(16):1263. PubMed ID: 9565004
    [No Abstract]   [Full Text] [Related]  

  • 14. Orogenital ulcerations in mixed connective tissue disease.
    Hamza M
    J Rheumatol; 1985 Jun; 12(3):643-4. PubMed ID: 4045874
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical aspects, diagnosis, differential diagnosis and therapy of mixed connective tissue disease (Sharp syndrome)].
    Mödder B; Feltkamp H; Mies R; Thiele KG
    Med Welt; 1980 Sep; 31(37):1305-7. PubMed ID: 7432125
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixed connective tissue disease.
    Carcassi U
    Panminerva Med; 1980; 22(2):73-6. PubMed ID: 7208085
    [No Abstract]   [Full Text] [Related]  

  • 17. Overlap syndromes and mixed connective tissue diseases.
    Maddison PJ
    Rep Rheum Dis; 1981 Jan; (76):2 pp.. PubMed ID: 7209114
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mixed connective tissue disease. Clinico-immunological studies in 12 patients].
    Chwalińska-Sadowska H; Jedryka-Góral A; Małdykowa H; Rdułtowska H
    Reumatologia; 1983; 21(3-4):221-9. PubMed ID: 6200908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mixed connective tissue disease].
    Nasonova VA; Folomeeva OM; Ivanova SM; Savorovskiĭ AI; Ivanova MM
    Ter Arkh; 1982; 54(6):12-8. PubMed ID: 7112409
    [No Abstract]   [Full Text] [Related]  

  • 20. Late onset mixed connective tissue disease.
    González-La Riviere O; Alarcón-Segovia D
    J Rheumatol; 1986 Apr; 13(2):471. PubMed ID: 3723514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.